The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS: a five-year follow-up.
D000636:Aminosalicylic Acids / Q000494:pharmacology*; D003523:Cycloserine / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D011013:Pneumonectomy; D011718:Pyrazinamide / Q000627:therapeutic use*; D013307:Streptomycin / Q000494:pharmacology*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000601:surgery*; D014756:Viomycin / Q000627:therapeutic use*
D000636:Aminosalicylic Acids; D011718:Pyrazinamide; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin